{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:20:53Z","timestamp":1787656853331,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/Objective<\/jats:title>\n                    <jats:p>The primary treatment for penile squamous cell carcinoma (PSCC) is often partial or total penectomy, which causes significant functional morbidity and psychological distress. Brachytherapy (BT) has emerged as a primary, organ-preserving alternative. The objective of this systematic review was to analyze the oncologic efficacy, organ preservation rates, and functional outcomes of LDR, PDR, and HDR brachytherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This systematic review (PROSPERO: CRD420251136499) followed PRISMA guidelines. We searched PubMed, Scopus, ScienceDirect, and Google Scholar (to August 2025) for studies (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009\u2265\u200910) reporting clinical outcomes of LDR, PDR, or HDR brachytherapy for adult penile cancer. Risk of bias was assessed using NIH tools and the Cochrane RoB tool. Due to high heterogeneity in study design and treatment techniques, a quantitative synthesis (narrative) was performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighteen studies were included. Five-year cancer-specific survival (CSS) ranged from 85.0 to 100% across 9 studies that explicitly reported this metric. Local failures, when they occurred, were demonstrated to be highly salvageable (77\u2013100% success).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The evidence, though limited and highly heterogeneous, confirms that penile brachytherapy is an effective, curative-intent, organ-sparing treatment for T1\u2013T2 disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11255-026-05135-y","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:28:05Z","timestamp":1776392885000},"page":"3419-3438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Organ-sparing radiotherapy in penile cancer: therapeutic approaches"],"prefix":"10.1007","volume":"58","author":[{"given":"Avraam","family":"Muresan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai Domnutiu","family":"Suciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad Horia","family":"Schitcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberth-Istvan","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Maria","family":"Muresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Kacso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"5135_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","volume":"20","author":"DM Backes","year":"2009","unstructured":"Backes DM, Kurman RJ, Pimenta JM, Smith JS (2009) Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 20:449\u2013457. https:\/\/doi.org\/10.1007\/s10552-008-9276-9","journal-title":"Cancer Causes Control"},{"issue":"295","key":"5135_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.urolonc.2018.12.003","volume":"37","author":"O Schoffer","year":"2019","unstructured":"Schoffer O, Neumann A, Stabenow R, Sch\u00fclein S, B\u00f6hm W-D, Gonsior A, Horn L-C, Kriegel C, Stolzenburg J-U, Wirth M et al (2019) Penile cancer \u2013 incidence, mortality, and survival in saxony, germany. Urol Oncol Semin Original Investigations 37(295):e1-295.e8. https:\/\/doi.org\/10.1016\/j.urolonc.2018.12.003","journal-title":"Urol Oncol Semin Original Investigations"},{"key":"5135_CR3","volume-title":"Cancer facts & figures 2025","author":"American Cancer Society","year":"2025","unstructured":"American Cancer Society (2025) Cancer facts & figures 2025. American Cancer Society, Atlanta"},{"key":"5135_CR4","unstructured":"Pettaway CA Carcinoma of the penis: epidemiology, risk factors, and pathology 2025"},{"key":"5135_CR5","volume-title":"Abeloff\u2019s clinical oncology","author":"JE Heinlen","year":"2020","unstructured":"Heinlen JE, Ramadan MO, Stratton K, Culkin DJ (2020) Chapter 82: Cancer of the penis. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE (eds) Abeloff\u2019s clinical oncology. Elsevier, Philadelphia"},{"key":"5135_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13027-020-00293-9","volume":"15","author":"A Cassell","year":"2020","unstructured":"Cassell A, Yunusa B, Manobah B, Wambo D (2020) Management guidelines of penile cancer- a contemporary review of Sub-Saharan Africa. Infect Agents Cancer 15:26. https:\/\/doi.org\/10.1186\/s13027-020-00293-9","journal-title":"Infect Agents Cancer"},{"key":"5135_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00345-011-0802-0","volume":"31","author":"A Chaux","year":"2013","unstructured":"Chaux A, Netto GJ, Rodr\u00edguez IM, Barreto JE, Oertell J, Ocampos S, Boggino H, Codas R, Xavier Bosch F, De Sanjose S et al (2013) Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol 31:861\u2013867. https:\/\/doi.org\/10.1007\/s00345-011-0802-0","journal-title":"World J Urol"},{"key":"5135_CR8","unstructured":"Brouwer O, Tagawa S, Albersen M others EAU-ASCO Collaborative Guidelines on Penile Cancer (2023). In: Proceedings of the 38th Annual EAU Congress"},{"key":"5135_CR9","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.21037\/tau-20-1228","volume":"10","author":"FA Stroie","year":"2021","unstructured":"Stroie FA, Houlihan MD, Kohler TS (2021) Sexual function in the penile cancer survivor: a narrative review. Transl Androl Urol 10:2544\u20132553. https:\/\/doi.org\/10.21037\/tau-20-1228","journal-title":"Transl Androl Urol"},{"key":"5135_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/1008-682X.168690","volume":"19","author":"S Sansalone","year":"2017","unstructured":"Sansalone S, Silvani M, Leonardi R, Vespasiani G, Iacovelli V (2017) Sexual outcomes after partial penectomy for penile cancer: results from a multi-institutional study. Asian J Androl 19:57. https:\/\/doi.org\/10.4103\/1008-682X.168690","journal-title":"Asian J Androl"},{"key":"5135_CR11","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/cancers16071309","volume":"16","author":"VM Torres Irizarry","year":"2024","unstructured":"Torres Irizarry VM, Paster IC, Ogbuji V, Gomez DM, Mccormick K, Chipollini J (2024) Improving quality of life and psychosocial health for penile cancer survivors: a narrative review. Cancers 16:1309. https:\/\/doi.org\/10.3390\/cancers16071309","journal-title":"Cancers"},{"key":"5135_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2022.08.021","volume":"169","author":"KA Diaz","year":"2022","unstructured":"Diaz KA, Spiess PE, Garc\u00eda-Perdomo HA (2022) Patient-reported outcomes in penile cancer patients: quality of life, sexual and urinary function. What do we know? Urology 169:1\u20135. https:\/\/doi.org\/10.1016\/j.urology.2022.08.021","journal-title":"Urology"},{"key":"5135_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/bju.15297","volume":"127","author":"E Roussel","year":"2021","unstructured":"Roussel E, Peeters E, Vanthoor J, Bozzini G, Muneer A, Ayres B, Sri D, Watkin N, Bhattar R, Parnham A et al (2021) Predictors of local recurrence and its impact on survival after glansectomy for penile cancer: Time to challenge the dogma? BJU Int 127:606\u2013613. https:\/\/doi.org\/10.1111\/bju.15297","journal-title":"BJU Int"},{"key":"5135_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.juro.2012.05.012","volume":"188","author":"P Philippou","year":"2012","unstructured":"Philippou P, Shabbir M, Malone P, Nigam R, Muneer A, Ralph DJ, Minhas S (2012) Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol 188:803\u2013808. https:\/\/doi.org\/10.1016\/j.juro.2012.05.012","journal-title":"J Urol"},{"key":"5135_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajur.2022.05.010","volume":"9","author":"A Patel","year":"2022","unstructured":"Patel A, Naghavi AO, Johnstone PA, Spiess PE, Grass GD (2022) Updates in the use of radiotherapy in the management of primary and locally-advanced penile cancer. Asian J Urol 9:389\u2013406. https:\/\/doi.org\/10.1016\/j.ajur.2022.05.010","journal-title":"Asian J Urol"},{"key":"5135_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/1756287219828972","volume":"11","author":"X Shen","year":"2019","unstructured":"Shen X, Parker W, Miller L, TenNapel M (2019) Opportunities for use of radiation therapy in penile cancer based on patterns of care in the United States from 2007 to 2013. Ther Adv Urol 11:1756287219828972. https:\/\/doi.org\/10.1177\/1756287219828972","journal-title":"Ther Adv Urol"},{"key":"5135_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.21037\/tau.2017.07.02","volume":"6","author":"MA Korzeniowski","year":"2017","unstructured":"Korzeniowski MA, Crook JM (2017) Contemporary role of radiotherapy in the management of penile cancer. Transl Androl Urol 6:855\u2013867. https:\/\/doi.org\/10.21037\/tau.2017.07.02","journal-title":"Transl Androl Urol"},{"key":"5135_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193424","volume":"16","author":"P Pathak","year":"2024","unstructured":"Pathak P, Thomas JJ, Baghwala A, Li C, Teh BS, Butler EB, Farach AM (2024) Personalized brachytherapy: applications and future directions. Cancers Basel 16:3424. https:\/\/doi.org\/10.3390\/cancers16193424","journal-title":"Cancers Basel"},{"key":"5135_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","volume":"78","author":"R P\u00f6tter","year":"2006","unstructured":"P\u00f6tter R, Haie-Meder C, Limbergen EV, Barillot I, Brabandere MD, Dimopoulos J, Dumas I, Erickson B, Lang S, Nulens A et al (2006) Recommendations from gynaecological (GYN) GEC ESTRO Working Group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy\u20143D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78:67\u201377. https:\/\/doi.org\/10.1016\/j.radonc.2005.11.014","journal-title":"Radiother Oncol"},{"key":"5135_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.radonc.2016.08.007","volume":"120","author":"K Tanderup","year":"2016","unstructured":"Tanderup K, Lindegaard JC, Kirisits C, Haie-Meder C, Kirchheiner K, De Leeuw A, J\u00fcrgenliemk-Schulz I, Van Limbergen E, P\u00f6tter R (2016) Image guided adaptive brachytherapy in cervix cancer: a new paradigm changing clinical practice and outcome. Radiother Oncol 120:365\u2013369. https:\/\/doi.org\/10.1016\/j.radonc.2016.08.007","journal-title":"Radiother Oncol"},{"key":"5135_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","volume":"22","author":"R P\u00f6tter","year":"2021","unstructured":"P\u00f6tter R, Tanderup K, Schmid MP, J\u00fcrgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B et al (2021) MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol 22:538\u2013547. https:\/\/doi.org\/10.1016\/S1470-2045(20)30753-1","journal-title":"Lancet Oncol"},{"key":"5135_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2025.104714","volume":"29","author":"J-M Hannoun-L\u00e9vi","year":"2025","unstructured":"Hannoun-L\u00e9vi J-M, Renard S, Pommier P, Houdou L, Mignot F, Charret J, Blanchard P, Chargari C, Ferr\u00e9 M (2025) Best practice in brachytherapy: 2025 update. Cancer Radiother 29:104714. https:\/\/doi.org\/10.1016\/j.canrad.2025.104714","journal-title":"Cancer Radiother"},{"key":"5135_CR23","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1118\/1.2981826","volume":"35","author":"BR Thomadsen","year":"2008","unstructured":"Thomadsen BR, Williamson JF, Rivard MJ, Meigooni AS (2008) Anniversary paper: past and current issues, and trends in brachytherapy physics. Med Phys 35:4708\u20134723. https:\/\/doi.org\/10.1118\/1.2981826","journal-title":"Med Phys"},{"key":"5135_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01378","volume":"9","author":"BW Fischer-Valuck","year":"2019","unstructured":"Fischer-Valuck BW, Gay HA, Patel S, Baumann BC, Michalski JM (2019) A brief review of low-dose rate (LDR) and high-dose rate (HDR) brachytherapy boost for high-risk prostate. Front Oncol 9:1378. https:\/\/doi.org\/10.3389\/fonc.2019.01378","journal-title":"Front Oncol"},{"key":"5135_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12094-008-0208-7","volume":"10","author":"A Polo","year":"2008","unstructured":"Polo A (2008) Pulsed dose rate brachytherapy. Clin Transl Oncol 10:324\u2013333. https:\/\/doi.org\/10.1007\/s12094-008-0208-7","journal-title":"Clin Transl Oncol"},{"key":"5135_CR26","first-page":"56","volume-title":"StatPearls","author":"AD Patel","year":"2024","unstructured":"Patel AD, Shah BB, King GT et al (2024) Brachytherapy. StatPearls. StatPearls Publishing, Treasure Island, pp 56\u201369"},{"key":"5135_CR27","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s11912-025-01666-2","volume":"27","author":"AM Chen","year":"2025","unstructured":"Chen AM (2025) HPV-mediated radiosensitivity in oropharyngeal squamous cell carcinoma: molecular mechanisms and cellular pathways. Curr Oncol Rep 27:634\u2013641. https:\/\/doi.org\/10.1007\/s11912-025-01666-2","journal-title":"Curr Oncol Rep"},{"key":"5135_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110373","volume":"200","author":"AM Chen","year":"2024","unstructured":"Chen AM (2024) De-escalated radiation for Human Papillomavirus virus-related oropharyngeal cancer: who, why, what, where, when, how, how much\u2026and what next? Radiother Oncol 200:110373. https:\/\/doi.org\/10.1016\/j.radonc.2024.110373","journal-title":"Radiother Oncol"},{"key":"5135_CR29","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.18632\/oncotarget.27535","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang M, Hong AM (2020) The Human Papillomavirus confers radiosensitivity in oropharyngeal cancer cells by enhancing DNA double strand break. Oncotarget 11:1417\u20131426. https:\/\/doi.org\/10.18632\/oncotarget.27535","journal-title":"Oncotarget"},{"key":"5135_CR30","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.8181","author":"L Iorga","year":"2019","unstructured":"Iorga L, Marcu R, Diaconu C, Stanescu A, Stoian A, Mischianu D, Surcel M, Bungau S, Constantin T, Boda D et al (2019) Penile carcinoma and HPV infection (review). Exp Ther Med. https:\/\/doi.org\/10.3892\/etm.2019.8181","journal-title":"Exp Ther Med"},{"key":"5135_CR31","doi-asserted-by":"publisher","first-page":"791","DOI":"10.21037\/tau.2017.06.27","volume":"6","author":"LC Kidd","year":"2017","unstructured":"Kidd LC, Chaing S, Chipollini J, Giuliano AR, Spiess PE, Sharma P (2017) Relationship between Human Papillomavirus and penile cancer\u2014implications for prevention and treatment. Transl Androl Urol 6:791\u2013802. https:\/\/doi.org\/10.21037\/tau.2017.06.27","journal-title":"Transl Androl Urol"},{"key":"5135_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13090809","volume":"13","author":"G Mannam","year":"2024","unstructured":"Mannam G, Miller JW, Johnson JS, Gullapalli K, Fazili A, Spiess PE, Chahoud J (2024) HPV and penile cancer: epidemiology, risk factors, and clinical insights. Pathogens 13:809. https:\/\/doi.org\/10.3390\/pathogens13090809","journal-title":"Pathogens"},{"key":"5135_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.21037\/tau.2017.05.19","volume":"6","author":"A Douglawi","year":"2017","unstructured":"Douglawi A, Masterson TA (2017) Updates on the epidemiology and risk factors for penile cancer. Transl Androl Urol 6:785\u2013790. https:\/\/doi.org\/10.21037\/tau.2017.05.19","journal-title":"Transl Androl Urol"},{"key":"5135_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1271913","volume":"13","author":"LW Ashley","year":"2023","unstructured":"Ashley LW, Sutton KF, Ju A, Edwards G, Pasli M, Bhatt A (2023) A SEER database retrospective cohort of 547 patients with penile non-squamous cell carcinoma: demographics, clinical characteristics, and outcomes. Front Oncol 13:1271913. https:\/\/doi.org\/10.3389\/fonc.2023.1271913","journal-title":"Front Oncol"},{"key":"5135_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1375882","volume":"14","author":"N Thumma","year":"2024","unstructured":"Thumma N, Pitla N, Gorantla V, du Plessis M (2024) A comprehensive review of current knowledge on penile squamous cell carcinoma. Front Oncol 14:1375882. https:\/\/doi.org\/10.3389\/fonc.2024.1375882","journal-title":"Front Oncol"},{"key":"5135_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrclinonc.2015.218","volume":"13","author":"R Glynne-Jones","year":"2016","unstructured":"Glynne-Jones R, Tan D, Hughes R, Hoskin P (2016) Squamous-cell carcinoma of the anus: progress in radiotherapy treatment. Nat Rev Clin Oncol 13:447\u2013459. https:\/\/doi.org\/10.1038\/nrclinonc.2015.218","journal-title":"Nat Rev Clin Oncol"},{"key":"5135_CR37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1470-2045(17)30246-2","volume":"18","author":"AM Chen","year":"2017","unstructured":"Chen AM, Felix C, Wang P-C, Hsu S, Basehart V, Garst J, Beron P, Wong D, Rosove MH, Rao S et al (2017) Reduced-dose radiotherapy for Human Papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study. Lancet Oncol 18:803\u2013811. https:\/\/doi.org\/10.1016\/S1470-2045(17)30246-2","journal-title":"Lancet Oncol"},{"key":"5135_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.semradonc.2017.08.002","volume":"28","author":"PG Hawkins","year":"2018","unstructured":"Hawkins PG, Kadam AS, Jackson WC, Eisbruch A (2018) Organ-sparing in radiotherapy for head-and-neck cancer: improving quality of life. Semin Radiat Oncol 28:46\u201352. https:\/\/doi.org\/10.1016\/j.semradonc.2017.08.002","journal-title":"Semin Radiat Oncol"},{"key":"5135_CR39","doi-asserted-by":"publisher","first-page":"100469","DOI":"10.18632\/oncotarget.18761","volume":"8","author":"X Hu","year":"2017","unstructured":"Hu X, Huang J, Wen S, Fu J, Chen M (2017) Comparison of efficacy between brachytherapy and penectomy in patients with penile cancer: a meta-analysis. Oncotarget 8:100469\u2013100477. https:\/\/doi.org\/10.18632\/oncotarget.18761","journal-title":"Oncotarget"},{"key":"5135_CR40","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2217\/fon-2020-0067","volume":"16","author":"H Menon","year":"2020","unstructured":"Menon H, Patel RR, Ludmir EB, Muralidhar V, Cushman TR, Amini A, Seyedin SN, Nguyen PL, Verma V (2020) Local management of preinvasive and clinical T1-3 penile cancer: utilization of diverse treatment modalities. Future Oncol 16:955\u2013960. https:\/\/doi.org\/10.2217\/fon-2020-0067","journal-title":"Future Oncol"},{"key":"5135_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.euros.2022.04.002","volume":"40","author":"VI Sakalis","year":"2022","unstructured":"Sakalis VI, Campi R, Barreto L, Garcia-Perdomo HA, Greco I, Zapala \u0141, Kailavasan M, Antunes-Lopes T, Marcus JD, Manzie K et al (2022) What is the most effective management of the primary tumor in men with invasive penile cancer: a systematic review of the available treatment options and their outcomes. Eur Urol Open Sci 40:58\u201394. https:\/\/doi.org\/10.1016\/j.euros.2022.04.002","journal-title":"Eur Urol Open Sci"},{"key":"5135_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"5135_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5114\/jcb.2010.19495","volume":"2","author":"R Makarewicz","year":"2010","unstructured":"Makarewicz R, Lebioda A, Terlikiewicz J, Kabaci\u0144ska R (2010) Interstitial brachytherapy for penile cancer: the experience of oncology centre in Bydgoszcz. J Contemp Brachytherapy 2:157\u2013159. https:\/\/doi.org\/10.5114\/jcb.2010.19495","journal-title":"J Contemp Brachytherapy"},{"key":"5135_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.brachy.2010.05.007","volume":"10","author":"J Petera","year":"2011","unstructured":"Petera J, Sir\u00e1k I, Ka\u0161aov\u00e1 L, Ma\u010dingov\u00e1 Z, Paluska P, Zouhar M, Kut\u00edlek P, Brod\u2019\u00e1k M, Vo\u0161mik M (2011) High\u2013dose rate brachytherapy in the treatment of penile carcinoma\u2014first experience. Brachytherapy 10:136\u2013140. https:\/\/doi.org\/10.1016\/j.brachy.2010.05.007","journal-title":"Brachytherapy"},{"key":"5135_CR45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.brachy.2013.06.001","volume":"13","author":"B Delaunay","year":"2014","unstructured":"Delaunay B, Soh PN, Delannes M, Riou O, Malavaud B, Moreno F, Craven J, Soulie M, Huyghe E (2014) Brachytherapy for penile cancer: efficacy and impact on sexual function. Brachytherapy 13:380\u2013387. https:\/\/doi.org\/10.1016\/j.brachy.2013.06.001","journal-title":"Brachytherapy"},{"key":"5135_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-9-142","volume":"9","author":"Y Rouscoff","year":"2014","unstructured":"Rouscoff Y, Falk AT, Durand M, Gal J, Chand M-E, Gautier M, Marsaud A, Chevallier D, Amiel J, Hannoun-Levi J-M (2014) High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis. Radiat Oncol 9:142. https:\/\/doi.org\/10.1186\/1748-717X-9-142","journal-title":"Radiat Oncol"},{"key":"5135_CR47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.brachy.2014.06.003","volume":"13","author":"DN Sharma","year":"2014","unstructured":"Sharma DN, Joshi NP, Gandhi AK, Haresh KP, Gupta S, Julka PK, Rath GK (2014) High-dose-rate interstitial brachytherapy for T1\u2013T2-stage penile carcinoma: short-term results. Brachytherapy 13:481\u2013487. https:\/\/doi.org\/10.1016\/j.brachy.2014.06.003","journal-title":"Brachytherapy"},{"key":"5135_CR48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.clon.2015.03.010","volume":"27","author":"L Kamsu-Kom","year":"2015","unstructured":"Kamsu-Kom L, Bidault F, Mazeron R, Baratiny C, Martin V, Maroun P, Dumas I, Guemnie-Tafo A, Martinetti F, Gerbaulet A et al (2015) Clinical experience with pulse dose rate brachytherapy for conservative treatment of penile carcinoma and comparison with historical data of low dose rate brachytherapy. Clin Oncol (R Coll Radiol) 27:387\u2013393. https:\/\/doi.org\/10.1016\/j.clon.2015.03.010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"5135_CR49","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.brachy.2015.01.005","volume":"14","author":"A Pimenta","year":"2015","unstructured":"Pimenta A, Gutierrez C, Mosquera D, Pera J, Mart\u00ednez E, Londres B, Pino F, Moreno S, Garcia M, Guedea F (2015) Penile brachytherapy-retrospective review of a single institution. Brachytherapy 14:525\u2013530. https:\/\/doi.org\/10.1016\/j.brachy.2015.01.005","journal-title":"Brachytherapy"},{"key":"5135_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-016-0676-9","volume":"11","author":"A Cordoba","year":"2016","unstructured":"Cordoba A, Escande A, Lopez S, Mortier L, Mirabel X, Coche-D\u00e9queant B, Lartigau E (2016) Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients). Radiat Oncol 11:96. https:\/\/doi.org\/10.1186\/s13014-016-0676-9","journal-title":"Radiat Oncol"},{"key":"5135_CR51","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00066-016-0968-x","volume":"192","author":"J Seibold","year":"2016","unstructured":"Seibold J, Strnad V, Fietkau R (2016) Organ-sparing treatment of penile cancer with interstitial pulsed-dose-rate brachytherapy. Strahlenther Onkol 192:467\u2013472. https:\/\/doi.org\/10.1007\/s00066-016-0968-x","journal-title":"Strahlenther Onkol"},{"key":"5135_CR52","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ijrobp.2017.02.090","volume":"99","author":"A Escande","year":"2017","unstructured":"Escande A, Haie-Meder C, Mazeron R, Maroun P, Cavalcanti A, De Crevoisier R, Schernberg A, Marsolat F, Blanchard P, Martinetti F et al (2017) Brachytherapy for conservative treatment of invasive penile carcinoma: prognostic factors and long-term analysis of outcome. Int J Radiat Oncol Biol Phys 99:563\u2013570. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.02.090","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5135_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.brachy.2017.09.006","volume":"17","author":"D Gambachidze","year":"2018","unstructured":"Gambachidze D, Lebacle C, Maroun P, Escande A, Bossi A, Blanchard P, Deutsch E, Haie-Meder C, Chargari C (2018) Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma. Brachytherapy 17:221\u2013226. https:\/\/doi.org\/10.1016\/j.brachy.2017.09.006","journal-title":"Brachytherapy"},{"key":"5135_CR54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.brachy.2019.03.006","volume":"18","author":"S Kellas-\u015al\u0119czka","year":"2019","unstructured":"Kellas-\u015al\u0119czka S, Bia\u0142as B, Fija\u0142kowski M, Wojcieszek P, Szlag M, Cholewka A, Weso\u0142owski M, \u015al\u0119czka M, Krzysztofiak T, Larysz D et al (2019) Nineteen-year single-center experience in 76 patients with penile cancer treated with high-dose-rate brachytherapy. Brachytherapy 18:493\u2013502. https:\/\/doi.org\/10.1016\/j.brachy.2019.03.006","journal-title":"Brachytherapy"},{"key":"5135_CR55","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brachy.2019.12.003","volume":"19","author":"M Marb\u00e1n","year":"2020","unstructured":"Marb\u00e1n M, Crook J, Keyes M, Dubash R, Batchelar D (2020) High-dose-rate brachytherapy for localized penile cancer: evolution of a technique. Brachytherapy 19:201\u2013209. https:\/\/doi.org\/10.1016\/j.brachy.2019.12.003","journal-title":"Brachytherapy"},{"key":"5135_CR56","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5489\/cuaj.6762","volume":"15","author":"J Garisto","year":"2021","unstructured":"Garisto J, Nayan M, Fadaak K, Li K, Pandya A, Leao R, Chung P, Shridar SS, Helou J, Kulkarni GS (2021) Oncological outcomes in the management of cT1-T2 cN0 penile squamous cell carcinoma. Can Urol Assoc J 15:187\u2013191. https:\/\/doi.org\/10.5489\/cuaj.6762","journal-title":"Can Urol Assoc J"},{"key":"5135_CR57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ctro.2020.12.008","volume":"27","author":"N Martz","year":"2021","unstructured":"Martz N, Bodokh Y, Gautier M, Thamphya B, Schiappa R, Lam Cham Kee D, Chevallier D, Hannoun A, Chand M-E, Hannoun-Levi J-M (2021) High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis. Clin Transl Radiat Oncol 27:89\u201395. https:\/\/doi.org\/10.1016\/j.ctro.2020.12.008","journal-title":"Clin Transl Radiat Oncol"},{"key":"5135_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246248","author":"D Pohankov\u00e1","year":"2022","unstructured":"Pohankov\u00e1 D, Sir\u00e1k I, Vo\u0161mik M, Ka\u0161aov\u00e1 L, Grepl J, Paluska P, Holub L, \u0160pa\u010dek J, Hodek M, Kope\u010dek M et al (2022) High-dose-rate brachytherapy as an organ-sparing treatment for early penile cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14246248","journal-title":"Cancers (Basel)"},{"key":"5135_CR59","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.brachy.2024.02.007","volume":"24","author":"S Achkar","year":"2025","unstructured":"Achkar S, Bachir M, Bourdais R, Kissel M, Felefly T, Escande A, Espenel S, Sun R, Chargari C (2025) Implementation of 3D image-guided brachytherapy for penile cancer: impact of urethral dose on long-term morbidity. Brachytherapy 24:395\u2013403. https:\/\/doi.org\/10.1016\/j.brachy.2024.02.007","journal-title":"Brachytherapy"},{"key":"5135_CR60","doi-asserted-by":"publisher","unstructured":"Ka, K.; Cordoba, A.; Schiappa, R.; Martz, N.; Espenel, S.; Escande, A.; Demogeot, N.; Hannoun-Levi, J.M.; Chargari, C. Oncological Outcomes and Organ Preservation After Brachytherapy for Penile Carcinoma: A Multicentric Retrospective Study by the Brachytherapy Group of the French Society for Radiation Oncology. International Journal of Radiation Oncology*Biology*Physics 2025, S0360301625046449, https:\/\/doi.org\/10.1016\/j.ijrobp.2025.07.052.","DOI":"10.1016\/j.ijrobp.2025.07.052"},{"key":"5135_CR61","unstructured":"Kolkman-Deurloo I.-K (2007) Intraoperative HDR brachytherapy: present and future"},{"key":"5135_CR62","doi-asserted-by":"publisher","DOI":"10.2196\/34874","volume":"8","author":"L Fu","year":"2022","unstructured":"Fu L, Tian T, Yao K, Chen X-F, Luo G, Gao Y, Lin Y-F, Wang B, Sun Y, Zheng W et al (2022) Global pattern and trends in penile cancer incidence: population-based study. JMIR Public Health Surveill 8:e34874. https:\/\/doi.org\/10.2196\/34874","journal-title":"JMIR Public Health Surveill"},{"key":"5135_CR63","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.brachy.2015.03.008","volume":"14","author":"S Hasan","year":"2015","unstructured":"Hasan S, Francis A, Hagenauer A, Hirsh A, Kaminsky D, Traughber B, Abouassaly R, Ellis R (2015) The role of brachytherapy in organ preservation for penile cancer: a meta-analysis and review of the literature. Brachytherapy 14:517\u2013524. https:\/\/doi.org\/10.1016\/j.brachy.2015.03.008","journal-title":"Brachytherapy"},{"key":"5135_CR64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1464-410X.2012.11597.x","volume":"111","author":"MR Cooperberg","year":"2013","unstructured":"Cooperberg MR, Ramakrishna NR, Duff SB, Hughes KE, Sadownik S, Smith JA, Tewari AK (2013) Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost\u2010utility analysis. BJU Int 111:437\u2013450. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11597.x","journal-title":"BJU Int"},{"key":"5135_CR65","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.prro.2020.02.014","volume":"10","author":"C Tang","year":"2020","unstructured":"Tang C, Lei X, Smith GL, Pan HY, Hess K, Chen A, Hoffman KE, Chapin BF, Kuban DA, Anscher M et al (2020) Costs and complications after a diagnosis of prostate cancer treated with time-efficient modalities: an analysis of national Medicare data. Pract Radiat Oncol 10:282\u2013292. https:\/\/doi.org\/10.1016\/j.prro.2020.02.014","journal-title":"Pract Radiat Oncol"},{"key":"5135_CR66","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2298\/ABS1304293N","volume":"65","author":"B Novac","year":"2013","unstructured":"Novac B, Ciobica A, Dobrin R, Ciobotaru M, Costache C (2013) Psychological\/psychiatric trauma in patients with penile cancer and partial or total penectomy. Arch biol sci (Beogr) 65:1293\u20131298. https:\/\/doi.org\/10.2298\/ABS1304293N","journal-title":"Arch biol sci (Beogr)"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05135-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05135-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05135-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:40:43Z","timestamp":1787654443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05135-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":66,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5135"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05135-y","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}